NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

COVID-19 and ICU-acquired MDR Bacteria

CompletedN/A

Sponsor: University Hospital, Lille

Conditions: Sars-CoV2, Critical Illness

Countries: France

This multicenter before-after study aimed to determine the impact of infection related to SARS-CoV-2 on the incidence of ICU-acquired multidrug resistant (MDR) bacteria.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Expected ICU stay \> 48 hours
* Rectal and nasal BMR screening performed \< 48 hours after admission to ICU

Exclusion Criteria:

* Patients aged \< 18 years Refusal to take part in the study ICU-stay \< 48 hours At least a second rectal and nasal BMR screening was not performed prior to ICU discharge (a posteriori exclusion criterion).

Locations (7)

Amiens, France
Béthune, France
Jossigny, France
Lens, France
Lille, France
Lyon, France
Lyon, France